The first of the CIBM Breakfast and Science Seminar Series 2022 was kick-started by Professor Valentina Garibotto, the new CIBM PET HUG UNIGE Section Head. “The lively discussion was very promising for many novel collaborations”, she said.
The interactive Q&A session was a welcome opportunity for knowledge sharing amongst the participants including students and researchers from throughout Switzerland: Empa in Zurich, University of Bern, Insel; University of Basel; and expert Professor John Prior, Head of the Nuclear Medicine and Molecular Imaging at Lausanne University Hospital.
The next Breakfast and Science Seminar Series, to be held February 22nd shall feature Professor Patrik Vuilleumier head of the newly founded CIBM MRI UNIGE Section.
How molecular imaging has changed our understanding of dementia
Division of Nuclear Medicine and Molecular Imaging, Diagnostic Department, HUG. NIMTLab, Radiology Department, Faculty of Medicine, UNIGE. CIBM PET HUG UNIGE Section
Abstract: In the last two decades, major efforts of the research community have focused on developing and validating biomarkers of disease processes in patients with cognitive disturbances. Molecular imaging with Positron emission tomography (PET) represents the only biomarker able to assess the presence and the topography of pathological deposits in the brain in vivo. These include namely amyloid and tau deposits, the two pathological hallmarks of Alzheimer’s Disease.
This has led to a paradigm change in our understanding of the disease onset and progression, from a description mainly based on symptoms in patients, to the assessment of disease markers in cognitively normal individuals to define risk profiles.
The talk will summarize the ongoing efforts of our group in Geneva, within a network of national and international collaborations, to contribute to these progresses in clinical practice.
About the Speaker: Pr. Valentina Garibotto is division chair of nuclear medicine and molecular imaging at the University Hospitals of Geneva and associate professor at the Geneva University. She trained in Italy and Germany and then developed her clinical, research and teaching activity in Geneva. Her projects, mainly funded by the Swiss National Research foundation, the Velux Stiftung, the Schmidheiny and Aetas foundation, investigate molecular imaging, namely to guide diagnosis in neurodegenerative conditions, to discover causative and protecting factors and to support the development of novel therapeutic approaches. She has authored more than 190 peer reviewed articles (H index: 32, Web of Science) in the fields of clinical neuroimaging and nuclear medicine. She is Congress Chair Elected of the European Association of Nuclear Medicine, Chair of the Neuroimaging group of the Swiss Society of Nuclear Medicine and actively involved in a number of European initiatives developing and validating molecular imaging in cognitive disturbances.
Seminar chair: Francois Lazeyras, Head of CIBM MRI HUG-UNIGE Clinical MR Imaging Section
The monthly meet-up seminar series is a great environment to ask questions or to share insights on challenges and solutions. It’s also a good way to broaden and enrich professional networks.